what is similar to semaglutide for weight loss GLP-1 vs Tirzepatide in Adults Semaglutide GLP-1 vs Ozempic vs

Your healthcare provider can help determine the cause and recommend an appropriate course of action

Higher maintenance doses were generally linked with greater weight loss, especially when patients stayed on treatment for longer

Table of Contents What Is Retatrutide and Its Current Development Status in the UK Risks of Sourcing Unregulated Peptides Online MHRA Guidance on Unlicensed Weight Loss Treatments Approved Alternatives Available Through NHS and Private Clinics How to Speak to a UK Doctor About Emerging Weight Loss Options Scientific References Frequently Asked Questions What Is Retatrutide and Its Current Development Status in the UK Retatrutide is an investigational triple incretin receptor agonist (GLP-1, GIP, and glucagon) developed by Eli Lilly that remains in Phase 3 trials and holds no MHRA marketing authorisation as of mid-2025

If you have any questions about your compounded semaglutide or other weight loss solutions, dont hesitate to reach out